m gurdalaMikołaj Gurdała
Innovation and Regional Manager for North East Europe, EIT Health InnoStars.
Mikołaj Gurdała is an expert with extensive experience experienced in EU funds, technology transfer and R&D. He has considerable expertise of international affairs and cross-sectoral cooperation. With EIT Health, one of the biggest healthcare organisations in Europe, he is responsible for developing international joint ventures and innovative projects co-created with academia and industry partners. He was one of the founders of building in Europe so called InnoStars Region within the EIT Health organisation, with aims to develop digital health, medtech and biotech innovations in the emerging markets.  Before joining EIT Health, Mikołaj Gurdała was a CEO and co-founder of Flavopharma, as well as being a director for Research, Strategies and Development at the Medical University of Łódź. Fields of expertise: supporting new ventures and start-ups in the ICT and life sciences sector, IP management and strategic development, change management, mentoring and coaching.

b kuruczBeata Kurucz
Regional Manager for Central and Eastern Europe, EIT Health InnoStars.
Beata Kurucz has over 20 years of experience in the healthcare industry. She is responsible for developing EIT Health programmes in Hungary, Slovakia, Romania and Croatia. Beata Kurucz, having deep-rooted economic background, is a qualified expert in the fields of EU projects and healthcare management.
Before joining EIT Health InnoStars, Beata Kurucz held a several managerial positions. Just to mention, she was a Director of Service Development by HT Medical Center based in Budapest, as well as Senior Manager for Signal Insurance Co. Health insurance division and CEO of Praxis Server Health Consulting Ltd.
Fields of expertise: development of new ventures and organisation’s divisions from the early-stage up to more mature ones; healthcare innovations.

p edwardsPaul Edwards MBE
Paul is the Managing Partner of Horton Global Healthcare, the healthcare arm of Horton International.
In his current role he has worked extensively in the UK, mainland Europe and Asia, with clients including major pharmaceutical companies, medical device organisations and early stage biotechnology companies. He has helped organisations to fill roles including Chairman, Chief Executive Officer and non-executive Directors, as well as senior Manufacturing, Operations, Commercial and R&D positions.
Prior to his career in Executive Search, he worked for Beecham Pharmaceuticals and Genzyme Corporation, where he headed the UK operations for the company. In 2000, he joined the UK based biosimilars’ organisation, GeneMedix plc as Chief Executive Officer, and successfully led a major funding round taking the company to a dual listing on the London and Singapore Stock Exchanges. More recently, Paul has acted as a NED to Goldshield Group plc and BioProducts Laboratories, and oversaw the sale of both organisations to Private Equity Groups.
Paul is a familiar face in the UK biotech arena, having been the Chairman of the UK BioIndustry Association’s Manufacturing Advisory Committee and was the recipient of the Donald Medal for services to Biochemical Engineering (1999). In 1997 he received an MBE for services to biotechnology.

k jarosinskaKarolina Jarosińska
ExecMind/Founder and Managing Director
Karolina is the Founder and Managing Director of ExecMind, Life Science Executive Search company, based in Krakow, Poland. She has been working in the recruitment industry for over 15 years and possesses significant experience in talent acquisition for senior scientific and C-level positions on European market. In 2015, she started ExecMind, and 4 years later, the company is a leader in scientific and executive recruitment in Poland for biotech, biopharma and medtech industries. The company is a member of internationally-recognized Life Sciences clusters.
Karolina holds a MA degree in sociology from the University of Szczecin. She continued her education by attending postgraduate studies in Human Resources, and in 2014/2015 she has completed another one-year postgraduate course on Business in Biotechnology (Jagiellonian University joint with Jagiellonian Centre of Innovation, Krakow, Poland). Karolina also successfully finished international courses in drug discovery and development.
Karolina is actively involved in integrating Life Science community in Poland. As a member of Life Science Cluster in Krakow, she supports and promotes cluster activities within biotech, pharma and medtech communities on the international stage.

m gwizdaMichał Gwizda
Managing partner at CRIDO | Business & innovations
Michał is the managing partner at Business and Innovation Team at CRIDO. He specializes in consulting projects regarding innovation and R+D. Michał works with companies at different stages of their innovation-based growth, and seamlessly combines various consulting capabilities from the realm of innovation, finances, taxes and public aid. He is at the helm of a team of 40 professionals, which for many
years now has regularly received accolades, from FORBES, among others, for its performance as the leader in obtaining EU funds in Poland. Michał has been in professional practice since 2002, specializing in
business consulting regarding public aid, innovation and EU funds. He started off his career in the Ministry of Finance and in one of the Big Four firms. He joined CRIDO at the very outset of our operations. He has been engaged in the process of molding Poland’s innovation policy and streamlining the administration’s abilities regarding the use of public funds.

r landesRonald Landes
Mr. Landes founded and led Landes Bioscience, publisher of 50 peer-reviewed life science journals, for 20 years. Currently he is CEO of the early-stage liver therapeutics start-up, von Baer Wolff, and serves on the board of directors and scientific advisory boards of several organizations. He has invested in approximately 25 early-stage life science companies in the US, Europe and Israel. Mr. Landes has a BS in biochemistry from the University of Chicago, an MD from the Medical College of Wisconsin and trained in surgery at the University of Minnesota.

r kozlowskiRoland Kozłowski
Roland received a first class hon¬ours degree from the University of Bath and a PhD from the University of Cambridge. He is a serial bio-entrepreneur, investor and mentor who has worked in the industry for over twenty five years. Roland was Chief Executive Officer of Lec-tus Therapeutics and Sense Proteomic Limited two venture capital backed companies which he founded, built and sold. During his career Roland has lead or played a key role in a many transactions including company financing, sale, purchase, financing and in- and out-licensing with a cumulative value of over $200m. Earlier in his career Roland ran Research Groups at the University of Oxford and University of Bristol where he published and patented in the life science field. He has been a Visiting Industrial Professor, served on, or advised the boards of several European companies and organizations including the Bio-Industry Association in the UK. Presently he is President and owner of Life Science Biznes Consulting which specializes in commercializing technology from emerging economies particularly in Poland. He has acted as an advisor to the National Centre of Research & Development in Poland and the Polish Development Agency. He is a founder and limited partner in Life Science Innovations a specialist VC fund based in Poland and a director or mentor to a number of start-up companies.

l nieradkoDr. Eng. Łukasz Nieradko
Business Development Directotr THERAPYRATF sp. z o.o.
Entrepreneur, strategy advisor of business and technology innovation development. Strong focus on market application and commercialization. Technology adviser and strategy development of product for market gaps finding. Team builder and project management specialist. Securing of IPR, technology commercialization and  start-up development. Nanotechnology, , energy storage, integrated optics, health, lab-on-the-chip, material science and digitalization of knowledge are the fields of expertise.

s powellSteven Powell
Steven graduated in microbiology from the University of Wales and was awarded a PhD from the University of Aberdeen.
He has over 30 years of operational and investment experience in pharmaceutical, diagnostics and medtech R&D. His operational experience includes appointments with Beecham Pharmaceuticals (GSK), Whatman, Celsis, Active Biotech, KS BioMedix, Plethora Solutions and Cambridge Cognition. In 2003 he joined Gilde Healthcare in the Netherlands, a pan-European life sciences investment fund where he continued to serve as an adviser to the fund until 2016.
He has extensive licensing and M&A experience and has raised finance in both public markets and through private equity and venture capital. He is currently CEO of eTheRNA Immunotherapies NV in Belgium and Chairman of UK public company, Cambridge Cognition Holdings PLC.

t weightmanTracy Weightman
Principal, Bridge Valley Ventures.
Tracy Weightman is a Principal at Bridge Valley Ventures and has over 15 years’ experience in venture capital, business development and project management. Tracy was previously an Investment Associate at Epidarex Capital, a £50m UK-based life science venture fund. During her time there she played a key role in the closure of four large Series A investments and several bridge financings. She was a key part of the team involved in the creation of Nodthera Ltd, which was based on research and development at Selvita SA. Prior to Epidarex, Tracy worked in business creation and business development functions at Edinburgh University and as a project manager for Quintiles, where she gained a strong track record in drug development. Tracy holds a BSc in Chemistry and an MBA, both from the University of Strathclyde.

j borgJohn J Borg, PhD
Pharmacist, specialised in Pharmacology currently serves as a Director at the Maltese Medicines Agency (ADM) and is responsible for EU centralised medicinal productevaluations; scientific advice and clinical
trials at the Maltese Medicines Agency.
Prof. Borg's professional trajectory has touched several areas of expertise from pre-clinical study to clinical activity as well as R&D of Ion Channel modulators,along with his commitment to teaching and regulatory activity, such as: national and international regulatory activities for the European union; preparation, evaluation and coordination of Research Projects; participation in international bodies etc.
Maltese member of the Committee for Human Medicinal Products (CHMP); member of the Committee on Advanced therapies (CAT); member of the Pharmacovigilance Risk AssessmentCommittee (PRAC); Member of the Paediatric Committee (PDCO); Co-Chair of the European Union Pharmacovigilance Oversight Group and member of the biologics working party (BWP) at the European Medicines Agency.
John J Borg trained at the University of Bristol and has published numerous scientific publications as well as chapters in books.